Crossmark

CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance

Published Online: 2023-11-22

Published Print: 2024-05

Authors

Xu, Zhujun
License Information

Text and Data Mining valid from 2023-11-22

Version of Record valid from 2023-11-22
More Information

Article History

Received: 13 October 2023

Accepted: 7 November 2023

First Online: 22 November 2023

Declarations

:

: Ethics approval for this type of article (A review) is not applicable.

: The authors declare no competing interests.

Document is current